SLC5A2 and type 2 diabetes mellitus: Initial studies of common functional polymorphisms identified in SLC5A2 suggested their influence on glucose homeostasis in non-diabetic subjects [14] however a recent study on T2D patients observed no significant effect of SLC5A2 genetic variability on patients' metabolic traits or their response to treatment with empagliflozin [15].